IUHSA
CYTK icon

Itau Unibanco Holding S.A.’s Cytokinetics CYTK Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-219
Closed -$8K – 508
2022
Q1 		$8K Buy
219
+12
+6% +$426 ﹤0.01% 436
2021
Q4 		$9K Buy
+207
New +$7.99K ﹤0.01% 398

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Itau Unibanco Holding S.A.'s CYTK Position: Q2 2022 in Review

Itau Unibanco Holding S.A. sold out of Cytokinetics (CYTK) in Q2 2022, closing a stake of 219 shares — an estimated $8K sold.

Itau Unibanco Holding S.A. first reported a position in CYTK in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 262 funds tracked by Wall St. Rank hold CYTK as of Q2 2022.

  • Itau Unibanco Holding S.A. reported no remaining Cytokinetics position as of Q2 2022 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 219 Cytokinetics shares in Q2 2022, an estimated $8K.
  • Itau Unibanco Holding S.A. first reported a position in Cytokinetics in Q4 2021 and held it in 2 quarters.
  • Itau Unibanco Holding S.A.'s Cytokinetics position peaked at $9K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2022, filed 15 Aug 2022.